Clinical Trial Update: New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update from the National Cancer Institute evaluating new therapeutic strategies for Ewing's sarcoma family tumors, high-risk rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma
• Rhabdomyosarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ewing's Sarcoma, Neuroblastoma | Phase 2 | Status: COMPLETED